A news item in Science reports on the failure of a xenotransplant after four months. Four months is not nothing. So kidneys from transgenic pigs remain in the future of clinical medicine, but maybe not the imminent future..
Longest human transplant of pig kidney fails. In latest xenotransplant test, Towana Looney’s body rejects gene-edited organ after more than 4 months 11 Apr 2025 By Jon Cohen
"Towana Looney, a 53-year-old grandmother from Alabama who received a kidney from a gene-edited pig on 25 November 2024, had it removed last week after the organ suddenly stopped functioning, Science has learned. The 4 months and 9 days Looney spent with the kidney set a new record for a pig organ in a human, but it is yet another setback for the long-struggling field known as xenotransplantation.
Looney had donated one kidney to her mother and then had her remaining one fail. For 9 years she had to schedule her life around dialysis, before having the transplant done at New York University (NYU) Langone Health. She was one of two recent recipients of kidneys from pigs in which U.S. companies did elaborate gene edits to make their tissues appear less foreign to the human immune system, and xenotransplant researchers had high hopes for these pioneering surgeries. (Chinese researchers in March reported their first xenotransplant of a gene-edited pig kidney, but few details have been made public.)
...
"The United States and other countries have long waiting lists for human organs, with many in need dying before they become eligible. Xenotransplantation for decades has held the prospect of addressing this crisis, but several approaches to preventing rejection of animal organs have failed to keep them functioning beyond a few months. Now, many in the field contend that a finer understanding of what the human immune system is reacting against on pig organs, simpler and cheaper tools to do gene edits in pigs, and improved drugs that suppress the immune system herald a new era for the field.
Surgeons at Massachusetts General Hospital on 25 January transplanted a gene-edited pig kidney made by a different company, eGenesis, to Tim Andrews, then 66. Andrews, who also is on immunosuppressive drugs, soon returned to his home in New Hampshire, but since has been hospitalized a few times for minor complications. Although eGenesis and Revivicor scientists have introduced several similar edits to the genomes of their pigs, such as three that eliminate pig-specific sugar molecules on cells that can trigger rejection, the kidney in Andrews has many that disable what are known as porcine endogenous retroviruses (PERVs). These remnants of ancient viruses have never caused an infection in humans, but the edits are an extra precautionary measure. Revivicor in contrast aimed to reduce that risk by selectively breeding pigs that did not have progeny with all of the genetic components necessary to reactivate PERVs."